Effect of Baduanjin Sequential Therapy on the Quality of Life and Cardiac Function in Patients with AMI After PCI: A Randomized Controlled Trial

Table 3

The changes of abdominal circumference and BMI during the 24 weeks.

Measure	Control group (n = 39)	BST (n = 43)	BST vs. control group (95% CI)	value
Abdominal circumference
Baseline	90.84 ± 9.44	87.87 ± 6.68	−2.96 (−6.61 to 0.68)	0.109
12 weeks	90.34 ± 7.00	86.89 ± 5.25	−3.45 (−6.25 to −0.65)	0.016
24 weeks	90.26 ± 7.10	85.98 ± 5.79	−4.29 (−7.18 to −1.39)	0.004
BMI
Baseline	24.62 ± 2.86	23.95 ± 2.35	−0.67 (−1.81 to 0.48)	0.249
12 weeks	24.57 ± 2.77	23.94 ± 2.33	−0.63 (−1.75 to 0.49)	0.268
24 weeks	24.60 ± 2.82	23.40 ± 2.30	−1.21 (−2.34 to −0.09)	0.035

BMI, body mass index. Data are presented as mean ± SD.